We are live on ! Find out more
TCM

Towercrest Capital Management Portfolio holdings

AUM $642M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
-11.1%
1 Year Est. Return
+11.71%
3 Year Est. Return
+31.42%
5 Year Est. Return
+23.73%
10 Year Est. Return
+78.8%
AUM
$447M
AUM Growth
-$65.8M
Cap. Flow
-$7.08M
Cap. Flow %
-1.58%
Top 10 Hldgs %
46.44%
Holding
94
New
3
Increased
32
Reduced
29
Closed
3
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
76
NextEra Energy
NEE
$181B
$264K 0.06%
3,402
+18
+0.5% +$1.37K
PM icon
77
Philip Morris
PM
$297B
$252K 0.06%
6,038
DTIL icon
78
Precision BioSciences
DTIL
$180M
$248K 0.06%
+5,156
New +$303K
FBND icon
79
Fidelity Total Bond ETF
FBND
$26.9B
$247K 0.06%
+5,300
New +$252K
HSY icon
80
Hershey
HSY
$35.2B
$237K 0.05%
1,100
QSR icon
81
Restaurant Brands International
QSR
$25.7B
$235K 0.05%
35,300
VIG icon
82
Vanguard Dividend Appreciation ETF
VIG
$111B
$235K 0.05%
1,637
PEG icon
83
Public Service Enterprise Group
PEG
$38.2B
$233K 0.05%
3,684
CPNG icon
84
Coupang
CPNG
$29.3B
$229K 0.05%
17,970
VEU icon
85
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$227K 0.05%
4,535
+90
+2% +$4.82K
ED icon
86
Consolidated Edison
ED
$40.1B
$226K 0.05%
2,374
GOOG icon
87
Alphabet (Google) Class C
GOOG
$4.36T
$221K 0.05%
2,020
OEF icon
88
iShares S&P 100 ETF
OEF
$20.1B
$217K 0.05%
1,257
SPSB icon
89
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$214K 0.05%
7,250
-223
-3% -$6.66K
LVS icon
90
Las Vegas Sands
LVS
$31.7B
$212K 0.05%
6,300
IBM icon
91
IBM
IBM
$211B
$208K 0.05%
+1,470
New +$198K
BA icon
92
Boeing
BA
$171B
-1,235
Closed -$237K
NVDA icon
93
NVIDIA
NVDA
$4.86T
-7,790
Closed -$213K
PHAS
94
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-1,051,940
Closed -$1.39M

Similar funds

Towercrest Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Towercrest Capital Management held 94 positions worth $447M, down 13% from $513M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Towercrest Capital Management's Q2 2022 filing shows 3 new, 32 increased, 29 reduced and 3 closed positions. Its largest new stake was Precision BioSciences: 5,156 shares worth $248K. The largest sale was Schwab US Aggregate Bond ETF, an estimated $3.82M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 2.9% a quarter earlier, followed by Communication Services and Healthcare.

  • Towercrest Capital Management's largest Q2 2022 buy was Precision BioSciences: 5,156 shares worth $248K.
  • Towercrest Capital Management added most to iShares Floating Rate Bond ETF in Q2 2022, an estimated $1.04M increase.
  • Towercrest Capital Management's biggest Q2 2022 reduction was Schwab US Aggregate Bond ETF, cutting an estimated $3.82M.
  • Towercrest Capital Management fully exited PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2022, selling an estimated $1.39M.
  • Towercrest Capital Management's ten largest holdings make up 46% of its $447M portfolio in Q2 2022.
  • Towercrest Capital Management opened 3 new positions and closed 3 in Q2 2022.
  • Towercrest Capital Management's portfolio value fell 13% quarter-over-quarter to $447M.

Based on Towercrest Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.